CNHC — China Health Management Share Price
Last trade - 00:00- $0.47m
- $8.47m
- $0.55m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.97 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -4482.82% | ||
Financial Summary
| Year End 30th Jun | Unit | 1996 | 1997 | 1998 | 1999 | 2000 | 2001E | 2002E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2 | 13.42 | 0.01 | 0.4 | 0.55 | n/a | n/a | -27.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Health Management Corp. is a healthcare and management company. The Company is focused on the operation and management of hospitals and the medical industry in China. The Company offers services, including medicine, surgery, gynaecology and obstetrics, paediatrics, emergency medicine, intensive care, stomatology, dermatology, medical cosmetology, preventive medicine, pharmacy, healthcare, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, anaesthesia, pathology, family wards, ophthalmology and otolaryngology, haemodialysis, commissioning hospital management, and hospital management consultation.
Directors
- Mary McAlpine PRE
- Robert Kuhnemund CEO (59)
- Leslie Crone CFO (52)
- Gary Raabe CTO (39)
- Gwynda Gee VOP (37)
- Lawrence Cahill DRC (68)
- Brian Norman DRC (32)
- Last Annual
- June 30th, 2000
- Last Interim
- March 31st, 2001
- Incorporated
- March 2nd, 2006
- Public Since
- July 11th, 2001
- No. of Shareholders
- 197
- No. of Employees
- 56
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 81,145,933
- Address
- 3609 Hammerkop Dr, NORTH LAS VEGAS, 89084-2413
- Web
- http://www.chinahealthcorp.com/
- Phone
- +1 4158413570
- Auditors
- Grant Thornton International
Similar to CNHC
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
As of Today at 19:05 UTC, shares in China Health Management are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in China Health Management last closed at $0.01 and the price had moved by -40.82% over the past 365 days. In terms of relative price strength the China Health Management share price has underperformed the S&P500 Index by -48.88% over the past year.
There is no consensus recommendation for this security.
China Health Management does not currently pay a dividend.
China Health Management does not currently pay a dividend.
China Health Management does not currently pay a dividend.
To buy shares in China Health Management you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in China Health Management had a market capitalisation of $0.47m.
Here are the trading details for China Health Management:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CNHC
Based on an overall assessment of its quality, value and momentum China Health Management is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Health Management. Over the past six months, its share price has underperformed the S&P500 Index by -35.69%.
As of the last closing price of $0.01, shares in China Health Management were trading -50.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The China Health Management PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
China Health Management's management team is headed by:
- Mary McAlpine - PRE
- Robert Kuhnemund - CEO
- Leslie Crone - CFO
- Gary Raabe - CTO
- Gwynda Gee - VOP
- Lawrence Cahill - DRC
- Brian Norman - DRC